Fortune

Nelson Peltz’s Twin Challenges

The famed activist investor thought his Trian hedge fund could work its magic on a pair of troubled stalwarts, General Electric and Procter & Gamble. They proved to be two bridges too far.

ON OCT. 1, when General Electric announced it had fired John Flannery, its CEO of just 14 months, one of the few people not at all shocked by the news was Nelson Peltz, the legendary activist investor. Flannery’s abrupt dismissal surprised even Wall Street analysts who obsessively follow the tarnished conglomerate. Yet Peltz wasn’t caught off guard, because his partner at the Trian hedge fund, Edward Garden, is on the GE board of directors that did the deed. Trian owns 71 million shares of GE stock, qualifying GE as Peltz’s most disastrous investment in a long, successful career. He’s down over $1 billion, about 50%, since buying in three years ago, with the stock’s latest drop following word of a federal criminal investigation into recently disclosed liabilities. With the brutally swift cashiering of Flannery, Peltz now understood change was afoot.

More than most, Peltz is comfortable with dramatic change. No other activist, a class of investors not content merely to watch from the sidelines, has prompted more of it. Among many activist forays, he instigated the transformation of DuPont into three independent companies after first combining with Dow Chemical. He forced the separation of Kraft into Kraft Foods Group and Mondelez International. He tried and failed to break up PepsiCo. He thinks big.

He has never thought bigger than he did with GE and with the other company at the top of his to-do list, Procter & Gamble. P&G is no disaster—its shares are up slightly since Peltz invested—and it’s decidedly more promising than GE. In November, the company announced a watered-down version of the reorganization plan he had been pushing. But the company is nowhere near

You're reading a preview, sign up to read more.

More from Fortune

Fortune24 min read
Paul Cox Has A Radical Theory For What’s Causing Alzheimer’s. Here’s Why We Should Listen.
IN A SMALL LAB IN JACKSON HOLE, Wyo., 65-year-old Paul Cox believes he’s closing in on a treatment that might prevent Alzheimer’s disease. And ALS. And a host of other neurodegenerative diseases, for that matter. Cox, we should point out, isn’t a neu
Fortune4 min read
The Internet Space Race
THE NEXT BILLION PEOPLE who get connected to the Internet may be looking to the heavens. That’s where a race is on to provide online access from fleets of satellites, led by a who’s who of tech and several deep-pocketed startups. The aim is to help
Fortune2 min read
Remembering Herb
ON A VISIT to Southwest Airlines’ headquarters in Dallas, employees strolling the corridors stop to chuckle at a kind of mirth-filled museum depicting its legendary cofounder hugging and mugging. Workers can gawk at a life-size cutout of Herb Kellehe